Why did Tesla's stock soar after robotaxi launch?
How will US-Iran conflict impact oil prices?
What caused Kroger to announce store closures?
Why are Fed officials signaling potential rate cuts?
How is the Iran strike affecting global markets?
What’s behind Compass suing Zillow over listings?
Why is Fiserv entering the stablecoin market?
Amgen Expands Development Plans For Highly Anticipated Obesity Drug
investors.com/news/technology/amgen-obesity-drug-maritide-eli-lilly-zepbound
Amgen said Monday it's expanding development plans for its weight-loss drug, MariTide, to include cardiovascular conditions and sleep apnea.
The post Amgen Expands Development Plans For Highly Anticipated Obesity Drug appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-06-23 18:30:00.